Lisa Patel

This inventor holds 16 USPTO granted patents and 1 published patent application, plus 4 CIPO patents and 4 EPO patents. Top assignees: Smithkline Beecham Corporation, Pimco 2664 Limited, Modern Biosciences Limited. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Patel. Retrieved from https://idiyas.com/inventor/lisa-patel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 16 (Patent Applications = 1)

% Patents Active = 87.5

CIPO Patents = 4 (Patent Applications = 6)

EPO Patents = 4 (Patent Applications = 10)

Average Co-Inventor Count = 2.1

ph-index = 3

Forward Citations = 48(Granted Patents)

Company Filing History:

6 out of 2,198

Smithkline Beecham Corporation

Modern Biosciences Limited

patents

4. 1 out of 1

Istesso Therapeutics Limited

patent

5. 2 out of 834,570

Other

patents

Years Active: 2001-2025

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12240814 - 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use (2025-03-04),

2. 12162836 - N-acyl-{4-[(4-aryl-phenyl)sulfonylmethyl]piperidine} compounds and their therapeutic use (2024-12-10),

3. 11834414 - 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol compounds and their therapeutic use (2023-12-05),

4. 10233147 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2019-03-19),

5. 10029979 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2018-07-24),

6. 10005733 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)-benzenesulfonamide compounds and their therapeutic use (2018-06-26),

7. 9796670 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2017-10-24),

8. 9624167 - N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamides and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamides and their therapeutic use (2017-04-18),

9. 6358721 - Human p101 regulatory polypeptide (2002-03-19),

10. 6348341 - Human p101 regulatory polypeptide (2002-02-19),

11. 6261819 - Compounds (2001-07-17),

12. 6258580 - P101 Polypeptides (2001-07-10),

13. 6238886 - Compounds (2001-05-29),

14. 6225090 - Compounds (2001-05-01),

15. 6200777 - Human p101 polynucleotides (2001-03-13),

Title: Innovator Spotlight: Lisa Patel and Her Contributions to Therapeutic Compounds

Introduction: Lisa Patel, a prominent inventor based in London, UK, has made significant strides in the field of therapeutic compounds. With a remarkable portfolio of 16 patents, her work focuses on developing innovative solutions for a variety of severe health disorders.

Latest Patents: Among her latest contributions, Patel has patented two key therapeutic compounds: 1-methyl-4-[(4-phenylphenyl)sulfonylmethyl]cyclohexyanol and 1-methyl-4-[[4-(2-pyridyl)phenyl]sulfonylmethyl]cyclohexanol. These compounds, collectively referred to as CHMSA compounds, are designed for the treatment of numerous diseases, including multiple myeloma, acute myeloid leukemia, and glioblastoma, among others. In addition, she has introduced N-acyl-{4-[(4-aryl-phenyl)sulfonylmethyl]piperidine} compounds, aimed at combating similar therapeutic challenges. Her inventions also encompass pharmaceutical compositions utilizing such compounds for effective therapy.

Career Highlights: Lisa Patel's career has seen her align with reputable organizations, including SmithKline Beecham Corporation and Pimco 2664 Limited. Her tenure in these companies has contributed significantly to her expertise in creating medical solutions through innovative compounds.

Collaborations: Over the years, Patel has collaborated with notable colleagues such as Colin Houston MacPhee and Stephen Allan Smith. These partnerships have played a crucial role in enhancing her research and development initiatives, driving forward her groundbreaking work.

Conclusion: Lisa Patel's contributions to therapeutic innovations are a testament to her dedication and expertise in the pharmaceutical field. With each patent, she brings us closer to better treatment options for some of the most challenging diseases, marking her as an influential inventor in today's medical landscape.

Profile summary based on public USPTO records.